P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy

Although electroconvulsive therapy (ECT) is among the most effective treatment options for pharmacoresistant major depressive disorder (MDD), some patients still remain refractory to standard ECT practise. Thus, there is a need for markers reliably predicting ECT non/response. In our study, we have...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Psychiatry
Autori principali: Neyazi, Alexandra, Theilmann, Wiebke, Brandt, Claudia, Rantamäki, Tomi, Matsui, Nobuaki, Rhein, Mathias, Kornhuber, Johannes, Bajbouj, Malek, Sperling, Wolfgang, Bleich, Stefan, Frieling, Helge, Löscher, Wolfgang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5802592/
https://ncbi.nlm.nih.gov/pubmed/29353887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41398-017-0077-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi